Clinical Trial

European Prospective Registry on Anomalous Aortic Origin of the Coronary Arteries

Study acronym: EUROAAOCA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 19, 2023 (before its estimated January 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Anomalous aortic origin of a coronary artery (AAOCA) is a group of rare congenital heart defects with various clinical presentations. The lifetime-risk of an individual living with AAOCA is unknown, and data from multicentre registries are urgently needed to adapt current recommendations and guide optimal patient management. The European Registry for AAOCA (EURO-AAOCA) aims to assess differences with regard to AAOCA management between centres.
Trial Details
NCT Number NCT06089902
Lead Sponsor University of Padova
Collaborators: IRCCS Policlinico S. Donato, Mitera Children's Hospital, Athens Heart Surgery Institute, Greece, Ospedale Civile Ca' Foncello, University Hospital, Ghent, Guy's and St Thomas' NHS Foundation Trust, Azienda Ospedaliera Universitaria Integrata Verona, University Medical Center Groningen, Hospital Universitario La Paz, Cliniques universitaires Saint-Luc- Université Catholique de Louvain, Insel Gruppe AG, University Hospital Bern, Azienda Ospedaliero-Universitaria di Parma
Conditions Congenital Heart Disease, Coronary Artery Anomaly, Sudden Cardiac Death, Surgical Procedure, Unspecified, Diagnosis, Arrhythmia, Heart Defects, Congenital, Adult Children
Enrollment 500 participants
Start Date 2019-01-01
Primary Completion 2025-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2023-10-19